(Q39345470)

11 September 2017

1 reference

title

Critical effects of epigenetic regulation in pulmonary arterial hypertension (English)

1 reference

11 September 2017

Dewei Chen

1

1 reference

11 September 2017

Wenxiang Gao

2

1 reference

11 September 2017

Shouxian Wang

3

1 reference

11 September 2017

Bing Ni

4

1 reference

11 September 2017

Yuqi Gao

5

1 reference

11 September 2017

1 June 2017

1 reference

Cellular and Molecular Life Sciences

11 September 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-017-2551-8

11 September 2017

0 references

cites work

Updated Clinical Classification of Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Molecular pathogenesis of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Mechanisms of disease: pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Endothelium-derived mediators and hypoxic pulmonary vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Inflammation, growth factors, and pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Lungs at high-altitude: genomic insights into hypoxic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Perceptions of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The emerging role of epigenetics in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Landscape of transcription in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The noncoding RNA revolution-trashing old rules to forge new ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The Landscape of long noncoding RNA classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Transcriptional and epigenetic regulation of human microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

microRNAs: tiny regulators with great potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

miRNAs in PAH: biomarker, therapeutic target or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA in pulmonary vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNAs in pulmonary arterial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MiRNA-199a-5p influences pulmonary artery hypertension via downregulating Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Targeting Protein-Protein Interactions in the HIF System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-138 inhibits hypoxia-induced proliferation of endothelial progenitor cells via inhibition of HIF-1α-mediated MAPK and AKT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

PPARgamma and the pathobiology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MiR-20a regulates the PRKG1 gene by targeting its coding region in pulmonary arterial smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Modulation of pulmonary vascular smooth muscle cell phenotype in hypoxia: role of cGMP-dependent protein kinase and myocardin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Elevated microRNA-135a is associated with pulmonary arterial hypertension in experimental mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

HIF-1 alpha-induced up-regulation of miR-9 contributes to phenotypic modulation in pulmonary artery smooth muscle cells during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Effect of miR-23a on anoxia-induced phenotypic transformation of smooth muscle cells of rat pulmonary arteries and regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1α/Fhl-1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

PPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Transcriptional regulation by calcium, calcineurin, and NFAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The role of nuclear factor of activated T cells in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Role for miR-204 in human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Role for DNA damage signaling in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA let-7g inhibited hypoxia-induced proliferation of PASMCs via G0/G1 cell cycle arrest by targeting c-myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Microrna-26b attenuates monocrotaline-induced pulmonary vascular remodeling via targeting connective tissue growth factor (CTGF) and cyclin D1 (CCND1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The adventitia: essential regulator of vascular wall structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Intergenic lncRNAs and the evolution of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Dynamic and Widespread lncRNA Expression in a Sponge and the Origin of Animal Complexity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Long non-coding RNAs: insights into functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Long noncoding RNA expression profiles of hypoxic pulmonary hypertension rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Regulation and function of miR-214 in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Predicting nucleosome positions on the DNA: combining intrinsic sequence preferences and remodeler activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Histone structure and nucleosome stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Regulation of chromatin structure by site-specific histone H3 methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Immunohistochemical Analysis of Histone H3 Modifications in Germ Cells during Mouse Spermatogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat: epigenetics in PAH following IUGR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Two Conserved Histone Demethylases Regulate Mitochondrial Stress-Induced Longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Mitochondrial Stress Induces Chromatin Reorganization to Promote Longevity and UPR(mt).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

BIX-01294 treatment blocks cell proliferation, migration and contractility in ovine foetal pulmonary arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Megakaryocytic leukemia 1 directs a histone H3 lysine 4 methyltransferase complex to regulate hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MRTF-A steers an epigenetic complex to activate endothelin-induced pro-inflammatory transcription in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Chromatin remodelling: the industrial revolution of DNA around histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

A role for DNA methylation in vertebrate gene expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Mitochondrial dynamics in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Phenotypic switching induced by damaged matrix is associated with DNA methyltransferase 3A (DNMT3A) activity and nuclear localization in smooth muscle cells (SMC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Extrauterine growth restriction on pulmonary vascular endothelial dysfunction in adult male rats: the role of epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Methylation Analysis of the BMPR2 Gene Promoter Region in Patients With Pulmonary Arterial Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Epigenetic control of gene expression: Potential implications for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Effect of Th17 and Treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Significance of miRNA-122 in chronic hepatitis C patients with serotype 1 on interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-017-2551-8

10.1007/S00018-017-2551-8

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference